USPUSP-NF
This is a preview of
USP-NF/PF content.
Subscriber?
Access here!
Not a subscriber?
Learn more!
Dapagliflozin
C21H25ClO6 408.88
d-​Glucitol, 1,​5-​anhydro-​1-​C-​[4-​chloro-​3-​[(4-​ethoxyphenyl)​methyl]​phenyl]​-​, (1S)​-​,;
(2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol [461432-26-8]

BRIEFING

Dapagliflozin. Because there is no existing USP monograph for this drug substance, a new monograph based on validated methods of analysis is proposed.

  1. The liquid chromatographic procedure used in the Assay was validated using the Kromasil C18 brand of column with L1 packing. The typical retention time for dapagliflozin is about 4 min.

  2. The liquid chromatographic procedure used in the Organic Impurities test was validated using the Kinetex XB-C18 brand of column with L1 packing. The typical retention time for dapagliflozin is about 13 min.

Description and solubility information: White to off-white powder or solid. Freely soluble in dimethylsulfoxide; soluble in ethanol; slightly soluble in water.

 (SM3: R. Fales)

 Case ID—SUB-67, SUB-278

This is a preview of
USP-NF/PF content.
Subscriber?
Access here!
Not a subscriber?
Learn more!